(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe. Read More
(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 100 was spared a steeper decline thanks to gains by pharmaceutical stocks. Read More
(Alliance News) - Stock prices in London mostly opened flat on Wednesday, with falls in FTSE 100 housebuilders, miners and oil majors offset by gains for pharmaceuticals as GSK shook off Zantac litigation. Read More
(Alliance News) - Stocks in London were set to start flat on Wednesday, as weak economic data from China pointed to a "deep malaise" in the global economy, though this was offset by news that Asia's largest economy will loosen its strict zero-Covid measures. Read More
(Alliance News) - Liberum described 2022 as a "tale of two indices", with the FTSE 100 resilient in the face of global turmoil, but the FTSE 250 succumbing to a rough year. Read More
(Alliance News) - Equities in Europe were celebrating a cooler-than-expected US CPI print on Thursday, which gave rise to hopes that peak inflation in the US has passed. Read More
(Alliance News) - Haleon PLC on Thursday reported a rise in quarterly revenue, but suffered a profit dip due to "standalone costs and adverse foreign exchange rates". Read More
(Alliance News) - Stocks in Europe struggled early on Thursday, though the FTSE 100 notched a minor gain, as investors held their breath ahead of all-important inflation data from the world's largest economy. Read More
(Alliance News) - Stocks in London are called lower on Thursday, with a stack of UK corporate updates keeping investors busy until the afternoon's eagerly-anticipated US inflation reading. Read More
(Alliance News) - GSK PLC on Wednesday raised its 2022 guidance and said its respiratory syncytial virus older adult vaccine candidate has been granted priority review by the US Food & Drug Administration. Read More
(Alliance News) - Haleon PLC on Monday announced the pricing for offers to exchange six series of outstanding unregistered notes issued by GSK Consumer Healthcare Capital US LLC and one series by GSK Consumer Healthcare Capital UK PLC due between 2024 and 2052, which Haleon announced on September 29. Read More
